 HOUSTON, Sept. 15, 2021 GLOBE NEWSWIRE -- Salarius Pharmaceuticals, Inc. Nasdaq: SLRX, a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, announced today that David Arthur, Chief Executive Officer, will present at the Life Science Investor Forum taking place September 16, 2021. The live, virtual presentation can be accessed via the conferences virtual platform by registered conference attendees. 